Market Research Future has just added another market concentrate to its broad research
portfolio, titled “Genetic Engineering Market Research Report- Forecast To 2027". The report
offers shrewd bits of knowledge and utilizations careful examination of market components
to measure advertise size and advancement.
Market Synopsis:
The Global Genetic Engineering Market is presumed to expand at 14.5 % CAGR during the
forecast period (2018-2027) owing to the growing technologies for gene therapy, asserts
Market Research Future (MRFR). Genetic engineering or genetic modification is the
manipulation of genes in an organism for enhancing its abilities. Genetic engineering is
generally used by biotechnology and pharmaceutical companies, and clinical research
organizations and is extensively used to treat cancer and other infectious disease.
Competitive Dashboard:
Transposagen Biopharmaceuticals Inc. (US)., New England Biolabs (U.S), Genentech Inc.
(US), Horizon Discovery Group Plc. (UK), Genscript Biotech Corporation (US), Origene
Technologies Inc. (US), Merck KGaA (Germany), Thermo Fisher Scientific Inc. (US),
Sangamo Therapeutics Inc. (US), Amgen Inc. (US), Lonza Group Ltd. (Switzerland),
Integrated DNA Technologies Inc. (US), and others.
Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/1528
Drivers and Constraints Impacting the Market:
Technologies such as ZNF, CRISPR/Cas9, and TALEN are extensively used in gene therapy
for various terminal illness and genetic disorders. Such emerging technologies and
innovations are likely to stimulate the market growth during the forecast period. Moreover,
with the widespread use of genetic engineering in developed countries, application in the
medicine industry, and special attention towards stem cells are presumed to foster the
market growth over the assessment period. Genetic engineering is estimated to be an
emerging trend in the medicine sector. For instance, organisms are used in the production
of insulin to treat patients suffering from chronic disease such as diabetes.
On the flip side, the inadequacy of trained professionals coupled with adverse public
perception associated with genetic research is some of the major factors likely to inhibit the
market growth in the coming years.
Global Genetic Engineering Market: Segmental Analysis
The Global Genetic Engineering Market has been segmented on the basis of devices,
product, application, techniques, end-users, and region.
By mode of product, the Global Genetic Engineering Market has been segmented into
genetic markers, biochemicals, and others. Among these, the biochemicals segment has
been further sub-segmented into RNAase, restriction enzymes, and others. The genetic
markers segment has been further sub-segmented into Amplified Fragment Length
Polymorphism, Restriction Fragment Length Polymorphism, Simple sequence length
polymorphism, and others.
By mode of devices, the global market has been segmented into gel assemblies, PCR, gene
gun, and others. Among these, the PCR segment is further sub-divided into Quantitative
PCR, Real-Time PCR, Reverse Transcription PCR, and others.
By mode of technique, the market has been segmented into gene splicing, cloning, artificial
selection, and others.
By mode of application, the market has been segmented into medical industry, agriculture,
forensic science, and others. The agriculture segment is further sub-divided into golden rice,
Bt- cotton, and others. The medical sector is sub-divided into recombinant antibodies,
recombinant proteins, and others.
By mode of end-users, the market has been segmented into academic institutes,
pharmaceutical industries, research institutes, and others.
Need Assistance @ https://www.marketresearchfuture.com/enquiry/1528
Regional Insights: